Shares of VEEM Ltd, the Perth-based marine propulsion and defense manufacturer, slid sharply this week after a blistering rally ran out of steam, raising questions about whether the company's pivot toward military contracts can justify a stock price that nearly doubled in days. VEEM's Defense Bet Sparked a Wild Rally — But With Revenue Falling and Shares Already Fading, Can the Story Outlast the Hype?
Shares of VEEM Ltd shifted dramatically this month as the Perth-based marine propulsion and defense manufacturer saw a placement-fueled surge evaporate almost as quickly as it arrived. The stock rocketed from $0.53 on June 10 to $0.63 by June 11 before collapsing back to $0.50 by June 16 — a 20% round-trip in under a week — leaving investors to weigh whether VEEM's ambitious defense pivot can deliver real financial returns or merely fleeting excitement.
• A $14 Million Cash Injection Lit the Fuse — But Diluted Existing Shareholders. VEEM completed a $14 million placement to institutional and sophisticated investors , with proceeds earmarked for expansion in the defense sector. While placements (selling new shares to raise cash) fund growth, they also dilute current holders' stakes. The speed of the subsequent sell-off suggests early buyers who chased the defense narrative quickly took profits once the news was fully priced in.
• Defense Contracts Look Impressive on Paper, But Revenue Is Still Shrinking. VEEM secured a six-year, $65 million contract renewal with ASC Pty Ltd to supply critical components for Australia's Collins Class submarines.
The company also achieved the highest tier of U.S. defense supplier qualification, positioning it to win orders from two of the largest American defense supply companies. Yet the most recent quarterly results tell a different story: revenue and EBITDA (a measure of operating profit) were down due to a global marine slowdown and delayed defense contracts.
Earnings per share came in at -$0.14, far worse than the estimated -$0.02.
• Analysts Still See Deep Value — If VEEM Can Execute. Two analysts rate the stock a "Buy" with an average $0.88 price target , implying roughly 76% upside from today's $0.50. But Morningstar has warned that "competition restrains long-term margins" , and the stock's 52-week range of $0.54 to $1.95 underscores extreme volatility for a company with a small market value.
• The Core Business Needs Defense Revenue to Arrive — Not Just Be Promised. FY 2025 revenue was $68.6 million with EBITDA of just $9.2 million , thin margins for a manufacturer betting on capital-intensive facility expansion. Major product launches and facility expansion support future growth, with defense and new technologies expected to drive higher sales — but until those purchase orders convert to cash, the stock remains a bet on a turnaround that has yet to materialize in the financial statements.